Blog

Learn from NIH and Johns Hopkins scientists as they share the importance of accurate extracellular vesicle quantification in their research: Overview of EV Quantification Methods including Spectradyne’s...

The quantification of cancer-derived exosomes has a strong potential for minimally invasive diagnosis of cancer during its initial stage. As cancerous exosomes form a small fraction of all the exosomes present in blood, ultra-sensitive detection is a prerequisite for the ...

ILIAS Biologics Inc, a leading exosome-based therapeutics company, announced today that the Company has completed a Series B financing round of $20.6 million in South Korea. The initial investors..

Mesenchymal stem cell (MSC)-derived exosomes have shown potential as an effective therapeutic tool for repairing bone defects. Researchers from the CHA University School of Medicine demonstrate...

A novel cascade signal amplification based on tyramide signal amplification (TSA) and surface-initiated enzymatic polymerization (SIEP) was first reported for the sensitive and template-free detection...

With the help of well-established Nanosight™ platform and advancing technologies, Creative Biolabs has optimized its exosome characterization services to facilitate exosome-related projects of global clients...

Mesenchymal stem/stromal cells (MSCs) provide therapeutic effects in many diseases. Contrary to initial hypotheses, they act in a paracrine rather...

Prostate cancer (PCa) is a leading cause of cancer death among men in the United States, with more than 3.6 million men living with prostate cancer...

Exosomes are generated within the multivesicular endosomes (MVEs) as intraluminal vesicles (ILVs) and secreted during the fusion of MVEs with the cell membrane. The mechanisms of exosome biogenesis

Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, today announced they have entered into a definitive agreement under which Illumina will...